Download:
pdf |
pdfPatient ID: _____ _____ _____ _____ _____ _____ _____ _____
– ACTIVE BACTERIAL CORE SURVEILLANCE CASE REPORT –
Phone No.: (
Patient's Name:
(Last, First, M.I.)
Address:
)
Patient
Chart No.:
(Number, Street, Apt. No.)
Hospital:
(Zip Code)
(City, State)
– Patient identifier information is NOT transmitted to CDC –
INVASIVE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) CASE REPORT
DEPARTMENT OF
HEALTH & HUMAN SERVICES
CENTERS FOR DISEASE CONTROL
AND PREVENTION
ATLANTA, GA 30333
1. STATE:
(Residence of
patient)
– SHADED AREAS FOR OFFICE USE ONLY –
2. COUNTY:
(Residence of Patient)
3. STATE I.D.:
5. Where was the patient a resident prior to admission at time of first
positive culture?
6. DATE OF BIRTH:
Mo.
1
Private Residence
1
Incarcerated
1
Long Term Care Facility
1
Transferred from hospital/acute care facility
1
Homeless
1
Other __________________________
8a. SEX:
1
8b. ETHNIC ORIGIN:
1
Male
2
Female
Form Approved OMB No. 0920-0009
Unk
7a. AGE:
Day
1
Hispanic or Latino
2
Not Hispanic or Latino
1
9
Unk
1
7b. Is age in day/mo/yr?
Year
1
8c. RACE: (Check all that apply)
1
4b. HOSPITAL I.D. WHERE
PATIENT TREATED
4a. HOSPITAL/LAB I.D. WHERE
CULTURE IDENTIFIED:
Days 2
Mos. 3
Yrs.
8d. WEIGHT:
Unk
_______ lbs _______ oz OR _______ kg
White
1
Asian
Black or
African American
American Indian
or Alaska Native
1
Native Hawaiian
or Other Pacific Islander
1
Unk
8e. HEIGHT:
Unk
_______ ft _______ in OR _______ cm
8f. TYPE OF INSURANCE: (Check all that apply)
1
Medicare
1
Medicaid/state assistance program
1
Private/HMO/PPO/managed care
1
No health coverage
1
Military/VA
1
Indian Health Service (HIS)
1
Other: (specify) __________________________
1
Unk
9. WAS PATIENT HOSPITALIZED?
1
Yes
2
No
9
Unk
If YES: Date of admission
Mo.
Day
Year
1
Date of discharge
Mo.
Day
11a. LOCATION OF CULTURE COLLECTION: (Check one)
10. WAS AN INFECTION RELATED
TO THE INITIAL CULTURE
INCLUDED IN THE ADMISSION
DIAGNOSIS? (Was MRSA infection
the reason for hospital admission?)
Year
Survived
Died
2
No
9
Unk
3
Emergency Room
9
Unk
4
Outpatient
10
Other: (specify)
11b. DATE OF INITIAL CULTURE:
Mo.
Day
Yes 2
No
Year
Date of Death:
Yes
2
Day
Year
No
9
Unk
1
Pregnant
2
Post-partum
3
Neither
9
Unk
13b. If pregnant or post-partun, what was the
outcome of the fetus:
Abortion/
4
Survived,
stillbirth
1
no apparent illness
2
Survived,
clinical infection
5
Induced
abortion
3
Live birth/neonatal
death
9
Unk
Unk
14. STERILE SITE(S) FROM WHICH MRSA WAS INITIALLY
ISOLATED: (Check all that apply)
1
Long Term Care Facility
___________________________________
If survived, was the patient transferred to a LTCF? 1
Was MRSA contributory or causal? 1
9
5
13a. At time of first positive
culture, patient was:
Mo.
2
Hospital Inpatient
Yes
12. PATIENT OUTCOME:
1
0
Blood
1
Joint/Synovial fluid
1
CSF
1
Bone
1
Pleural fluid
1
Internal body site (specify)
1
Peritoneal fluid
1
Pericardial fluid
_____________________________
1
Other sterile site (specify)
_____________________________
15. Were cultures of the SAME
sterile site(s) positive between
7 and 30 days after initial culture?
1
Yes
2
No 9
Unk
16. Were cultures of OTHER sterile site(s) positive
within 30 days of initial culture?
1
Yes
2
No 9
Unk
If Yes, list site(s):
1
Blood
1
Joint/Synovial fluid
1
CSF
1
Bone
1
Pleural fluid
1
Internal body site (specify)
1
Peritoneal fluid
1
Pericardial fluid
_______________________
1
Other sterile site (specify)
_______________________
Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data
needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB
control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, CDC/ATSDR Reports Clearance Officer,
1600 Clifton Road, MS E-11, Atlanta, GA 30333, ATTN: PRA (0920-0009).
CDC 52.15A Rev. 1-2008
– IMPORTANT – PLEASE COMPLETE THE BACK OF THIS FORM –
Page 1 of 2
17. TYPES OF MRSA INFECTION ASSOCIATED WITH CULTURE(S): (Check all that apply)
1
None
1
Unk
1
Bacteremia
1
Osteomyelitis
1
Surgical Site (internal)
1
Traumatic Wound
1
Empyema
1
Urinary Tract
1
Septic Arthritis
1
Surgical Incision
1
Meningitis
1
Endocarditis
1
Bursitis
1
Pressure Ulcer
1
Peritonitis
1
Skin Abscess
1
Septic Shock
1
Septic Emboli
1
Pneumonia (If checked, go
to question 21)
1
Abscess (not skin)
1
Cellulitis
1
Other: (specify)
___________________________________
___________________________________
18. UNDERLYING CONDITIONS: (Check all that apply) (if none or no chart available, check appropriate box)
1
None
1
Unk
1
Current Smoker
1
Peripheral Vascular Disease (PVD)
1
Sickle Cell Anemia
1
Decubitus Ulcer
1
Alcohol Abuse
1
Heart Failure/CHF
1
Diabetes
1
Eczema
1
IVDU
1
Atherosclerotic Cardiovascular
1
Chronic Renal Insufficiency
1
Influenza (within 10
1
Other Drug Use
Disease (ASCVD)/CAD
1
Chronic Liver Disease
1
HIV
1
CVA/Stroke (Not TIA)
1
Rheumatoid Arthritis
1
1
AIDS or CD4 count<200
1
Emphysema/COPD
1
Obesity
_________________________________________
1
Solid Organ Malignancy
1
Asthma
1
Premature Birth
1
1
Hematologic Malignancy
1
Systemic Lupus Erythematosus
1
Immunosuppressive Therapy
_________________________________________
19. CLASSIFICATION – Healthcare-associated and Community-associated: (Check all that apply)
1
1
1
Abscess/Boil
1
Psoriasis
days of initial culture)
None
Other Dermatological Condition(s): (specify)
Other condition(s): (specify)
1
Unk
Previous documented MRSA infection or colonization
Month
Year
OR previous STATE I.D.:
1
Surgery within year before index culture date.
1
Residence in a long-term care facility
within year before index culture date.
If YES:
1
Dialysis within year before index culture date.
(Hemodialysis or Peritoneal dialysis)
1
Central vascular catheter in place at
time of admission/evaluation.
1
Culture collected >48 hours after hospital admission.
1
Hospitalized within year before index culture date.
Month
Year
1
If YES:
Unk
20. SUSCEPTIBILITY RESULTS: [S=Sensitive (1), I = Intermediate (2), R = Resistant (3), U = Unknown/Not reported (9)]
Ciprofloxacin:
S
I
R
U
Oxacillin:
S
I
R
U
Cefazolin:
S
I
R
U
Clindamycin:
S
I
R
U
Penicillin:
S
I
R
U
Chloramphenicol:
S
I
R
U
Daptomycin:
S
I
R
U
Quinupristin/Dalfopristin:
S
I
R
U
Moxifloxacin:
S
I
R
U
Doxycycline:
S
I
R
U
Rifampin:
S
I
R
U
Nafcillin:
S
I
R
U
Erythromycin:
S
I
R
U
Tetracycline:
S
I
R
U
Ampicillin:
S
I
R
U
Gatifloxacin:
S
I
R
U
Trimethoprim-sulfamethoxazole:
S
I
R
U
Imipenem:
S
I
R
U
Gentamicin:
S
I
R
U
Vancomycin:
S
I
R
U
Levofloxacin:
S
I
R
U
Other:
S
I
R
U
Linezolid:
S
I
R
U
__________________________
21. SUPPLEMENTAL PNEUMONIA QUESTIONS. Please complete if the patient was determined to have pneumonia per question 17.
a. Are any of the following listed in the discharge summary narrative?
c. Chest Radiograph Results (Check all that apply) 1
1
MRSA pneumonia
1
Staphylococcal pneumonia
1
Pneumonia
1
No pneumonia specified
1
Aspiration pneumonia
b. Discharge diagnosis (Check all that apply) 1
1
482.40
1
482.41
1
482.49
N/A
1
1
V09.0
Unk
1
None listed
1
1
1
1
1
d. 1
Bronchopneumonia/pneumonia
Air space density/opacity
Cavitation
Cannot rule out pneumonia
New or changed infiltrates
1
1
1
1
Not done
Pleural effusion
Consolidation
Not available
Other: (specify)
______________________
MRSA positive non-sterile respiratory specimens
– SURVEILLANCE OFFICE USE ONLY –
22. Was case first
identified through
audit?
1
Yes
9
Unk
2
No
23. CRF status:
1
2
3
4
Complete
Incomplete
Edited & Correct
Chart unavailable
after 3 requests
24. Does this case have
recurrent MRSA
disease?
1
Yes
9
Unk
2
No
If YES, previous
(1st) STATE I.D.:
25. Date reported to EIP site:
Mo.
Day
26. Initials of
S.O:
Year
27. COMMENTS:_____________________________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________________________
CDC 52.15A Rev. 1-2008
Page 2 of 2
File Type | application/pdf |
File Title | Page1MRSA form |
Author | bjb1 |
File Modified | 2008-07-10 |
File Created | 2008-06-18 |